Last updated: 2026-09-09 19:19:20. Prices reflect the latest regular market data. Stock price data is sourced from Massive.
Aspire Biopharma Holdings, Inc. (ASBP) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $8.78, with a market capitalisation of $12.44M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $3.31 to $566.76. This page covers its latest market performance, valuation, price trends and company information.
$12.44M | |
$9.05 | |
$35,088.00 | |
$3.31 | |
$8.85 | |
108.52K | |
271.73K | |
-- | |
$566.76 | |
$3.31 | |
-- | |
-- |
Aspire Biopharma Holdings, Inc. (ASBP) is currently trading at $8.78 as of 2026-09-09 19:17:00, down 0.85% ($0.07) from the previous close of $8.85
During today's regular trading session, ASBP has traded between $3.31 and $35,088.00, with a trading volume of 108.52K shares. The current price is near the lower end of today's range.
Over the past seven days, Aspire Biopharma Holdings, Inc. (ASBP) moved from $8.51 to $8.78, representing a gain of 3.11% ($0.27).
The stock traded between $7.80 and $9.50 during the period. The latest price is near the middle of the 7-day range, indicating moderate upward.
The average daily volume was 31.66 thousand shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 1.0%
ASBP is currently trading at $8.78, placing it 1.0% of the way from its 52-week low of $3.31 to its 52-week high of $566.76. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Aspire Biopharma Holdings Inc is an early-stage biopharmaceutical company focused on developing and commercializing novel sublingual drug delivery technologies. The company is mainly engaged in advancing patent-pending formulations designed to enable rapid absorption of drugs, initially targeting high-dose aspirin products for cardiovascular and pain management applications. Its technology aims to improve efficacy and response time by bypassing the gastrointestinal tract through sublingual delivery.
| Industry | PHARMACEUTICAL PREPARATIONS |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Aspire Biopharma Holdings, Inc. (ASBP) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.